跳至主要内容
临床试验/ACTRN12617000571370
ACTRN12617000571370招募中4 期

Effects of low dose topical 0.01% atropine eye drops with and without benzalkonium chloride (BAK) preservative on the ocular surface in healthy adults

SW Sydney0 个研究点目标入组 20 人开始时间: 2017年4月24日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 40 Years(—)
性别
All

入选标准

  • 1) Adults aged between 18-40
  • 2) Informed consent received
  • 3) Have normal eye and general health
  • 4) No reported allergy to atropine or preservatives
  • 5) Willingness to comply with scheduled visits and other study procedures
  • 6) No history of narrow-angle glaucoma or risk of glaucoma

排除标准

  • 1) Atropine eye drop use prior to enrollment
  • 2) Any ocular disease including inflammation or allergy
  • 3) History of allergic reaction to any topical ophthalmic drugs
  • 4) Contact lens wearer
  • 5) Currently using topical ophthalmic drugs
  • 6) Anyone who is taking any form of medication
  • 7) Pregnant women, planning to become pregnant, or breast-feeding

研究者

发起方
SW Sydney

相似试验